ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

Endocrine Abstracts (2019) 63 GP251 | DOI: 10.1530/endoabs.63.GP251

Free Testosterone (FT) is inversely related to frailty in Human Immunodeficiency Virus (HIV)-Infected Men

Sara De Vincentis1,2, Maria Chiara Decaroli1,2, Chiara Diazzi2, Fabio Morini1, Davide Bertani1, Flaminia Fanelli3, Marco Mezzullo3, Daniele Santi1,2, Giulia Tartaro1,2, Enrica Baraldi4, Simonetta Tagliavini4, Uberto Pagotto3, Giovanni Guaraldi5 & Vincenzo Rochira1,2

1Unit of Endocrinology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy; 2Unit of Endocrinology, Department of Medical Specialties, Azienda Ospedaliero-Universitaria of Modena, Modena, Italy; 3Endocrinology Unit and Center for Applied Biomedical Research (CRBA), Department of Medical and Surgical Sciences, University of Bologna – S. Orsola-Malpighi Hospital, Bologna, Italy; 4Department of Laboratory Medicine and Anatomy Pathology, Azienda USL of Modena, Modena, Italy; 5Multidisciplinary Metabolic Clinic, Unit of Infectious Diseases, University of Modena and Reggio Emilia, Modena, Italy.

Background: HIV-infection is associated to several age-related comorbidities, such as a premature decline of serum testosterone (T). There is evidence about the relationship between health status, represented by frailty and comorbidities, and serum T levels in general population, while only one previous retrospective study investigated it in HIV-infected men.

Aim: To investigate the association between frailty and gonadal status by assessing serum total T (TT) with Liquid Chromatography tandem Mass Spectrometry (LC-MS/MS) in a cohort of HIV-infected men.

Methods: Prospective, cross-sectional, observational study on HIV-infected men (age <50 years) with ongoing Highly Active Antiretroviral Therapy (HAART). Serum TT was assessed by the gold standard ID-LC-MS/MS. Sex hormone-binding globulin (SHBG) was measured by chemiluminescent immunoassay. Free T (FT) was calculated by Vermeulen equation. Frailty was calculated through 38-items multimorbidity frailty index. Statistical analysis: Parameters were not normally distributed and Mann-Whitney U test was used to compare continuous variables. Correlations were performed using linear regression models.

Results: 315 consecutive HIV-infected men were enrolled (mean age 45.56±5.61 years; average duration of HIV-infection 16.30±8.57 years). 17 patients (5.4%) had TT below 320 ng/dl and 31 patients (9.8%) had calculated FT below 64 pg/ml. Overall, 37 patients (11.7%) had T deficiency defined by low TT levels and/or low FT. 56 patients (17.8%) showed SHBG above the normal range (>71.4 nmol/l). Frailty score (P=0.031), age (P=0.001), duration of HIV-infection and of HAART (P<0.0001) significantly differed between eugonadic and hypogonadic patients, while no difference was found for BMI (P=0.209). FT inversely correlated with frailty score (P=0.038, R2=0.014), while TT did not (P=0.235). At stepwise multivariate regression analysis, FT showed an inverse relation with age (P<0.0001, R2=0.150), years of infection (−0.339, P<0.0001, R2=0.125) and years of HAART (-0.346, P<0.0001, R2=0.117), but not with frailty score and BMI of patients.

Conclusions: To the best of our knowledge, this is the first properly-designed prospective study aiming to investigate the relationship between general health status and gonadal function in a cohort of HIV-infected men. FT is inversely related to frailty score, suggesting an impairment of gonadal function in those patients affected by more multimorbidities in this setting as well as in general population. At the same time, the age of patient and the duration of HIV-infection seem to be more potent predictive factors for serum FT levels than frailty score. In clinical practice it is important to check for testosterone in these patients due to frequent alterations of SHBG.